Escherichia coli, Enterobactin and Salmochelin Hydrolase IroE, Salmochelin siderophore protein
Comment
The proliferation of many pathogenic bacteria is limited by the scarcity of soluble iron in their environment. Many of these bacteria scavenge iron by synthesizing and exporting small molecule siderophores that chelate iron. Iron-bound siderophores are subsequently imported for metabolic processing. Three related serine hydrolases have been characterized biochemically in this pathway: Fes, IroD, and IroE. There are more than 200 strains. Other Uniprot entries and list of strains can be found with the link: Other strains
(Below N is a link to NCBI taxonomic web page and E link to ESTHER at designed phylum.) > cellular organisms: NE > Bacteria: NE > Proteobacteria: NE > Gammaproteobacteria: NE > Enterobacterales: NE > Enterobacteriaceae: NE > Escherichia: NE > Escherichia coli: NE
Warning: This entry is a compilation of different species or line or strain with more than 90% amino acide identity. You can retrieve all strain data
(Below N is a link to NCBI taxonomic web page and E link to ESTHER at designed phylum.) Escherichia coli NC101: N, E.
Escherichia coli MS 145-7: N, E.
Escherichia coli NA114: N, E.
Escherichia coli SE15: N, E.
Escherichia coli APEC O1: N, E.
Escherichia coli SMS-3-5: N, E.
Escherichia coli B088: N, E.
Escherichia coli B354: N, E.
Escherichia coli 536: N, E.
Escherichia coli MS 182-1: N, E.
Escherichia coli O26:H11 str. 11368: N, E.
Escherichia coli IAI1: N, E.
Escherichia coli O111:H- str. 11128: N, E.
Escherichia coli 042: N, E.
Escherichia coli DH1: N, E.
Escherichia coli O55:H7 str. CB9615: N, E.
Escherichia coli O103:H2 str. 12009: N, E.
Escherichia coli IHE3034: N, E.
Escherichia coli BL21: N, E.
Escherichia coli B str. REL606: N, E.
Escherichia coli O157:H7 str. TW14359: N, E.
Escherichia coli BL21(DE3): N, E.
Escherichia coli MS 185-1: N, E.
Escherichia coli MS 45-1: N, E.
Escherichia coli O157:H7 str. EC4501: N, E.
Escherichia coli FVEC1302: N, E.
Escherichia coli O157:H7 str. EC508: N, E.
Escherichia coli W: N, E.
Escherichia coli 53638: N, E.
Escherichia coli B171: N, E.
Escherichia coli O157:H7 str. EC4076: N, E.
Escherichia coli O157:H7 str. EC4113: N, E.
Escherichia coli MS 187-1: N, E.
Escherichia coli O157:H7 str. EC869: N, E.
Escherichia coli O157:H7 str. EC4486: N, E.
Escherichia coli 83972: N, E.
Escherichia coli MS 198-1: N, E.
Escherichia coli F11: N, E.
Escherichia coli O157:H7 str. EC4401: N, E.
Escherichia coli KO11FL: N, E.
Escherichia coli MS 196-1: N, E.
Escherichia coli MS 119-7: N, E.
Escherichia coli O157:H7 str. EC4196: N, E.
Escherichia coli MS 116-1: N, E.
Escherichia coli MS 115-1: N, E.
Escherichia coli O157:H7 str. TW14588: N, E.
Escherichia coli E110019: N, E.
Escherichia coli MS 175-1: N, E.
Escherichia coli 101-1: N, E.
Escherichia coli B185: N, E.
Escherichia coli UTI89: N, E.
Escherichia coli E24377A: N, E.
Escherichia coli O127:H6 str. E2348/69: N, E.
Escherichia coli S88: N, E.
Escherichia coli 55989: N, E.
Escherichia coli O157:H7 str. EC4115: N, E.
Escherichia coli IAI39: N, E.
Escherichia coli ED1a: N, E.
Escherichia coli BW2952: N, E.
Escherichia coli str. K-12 substr. DH10B: N, E.
Escherichia coli HS: N, E.
Escherichia coli ATCC 8739: N, E.
Escherichia coli UMN026: N, E.
Escherichia coli SE11: N, E.
Escherichia coli E22: N, E.
Escherichia coli MS 200-1: N, E.
Escherichia coli B7A: N, E.
Escherichia coli MS 21-1: N, E.
Escherichia coli FVEC1412: N, E.
Escherichia coli MS 107-1: N, E.
Escherichia coli MS 69-1: N, E.
Escherichia coli K-12: N, E.
Escherichia coli O111:H-: N, E.
Escherichia coli ETEC 1392/75: N, E.
Escherichia coli O26:H-: N, E.
Escherichia coli Vir68: N, E.
Escherichia coli EC4100B: N, E.
Escherichia coli WV_060327: N, E.
Escherichia coli O157:H7 str. EC1212: N, E.
Escherichia coli RN587/1: N, E.
Escherichia coli 1357: N, E.
Escherichia coli 1180: N, E.
Escherichia coli LT-68: N, E.
Escherichia coli E128010: N, E.
Escherichia coli EPECa14: N, E.
Escherichia coli O157:H- str. 493-89: N, E.
Escherichia coli O157:H- str. H 2687: N, E.
Escherichia coli O55:H7 str. 3256-97: N, E.
Escherichia coli O55:H7 str. USDA 5905: N, E.
Escherichia coli O157:H7 str. LSU-61: N, E.
Escherichia coli MS 146-1: N, E.
Escherichia coli MS 78-1: N, E.
Escherichia coli MS 124-1: N, E.
Escherichia coli ABU 83972: N, E.
Escherichia coli UM146: N, E.
Escherichia coli O157:H7 str. EC4206: N, E.
Escherichia coli O157:H7 str. EC4045: N, E.
Escherichia coli O157:H7 str. EC4042: N, E.
Escherichia coli 1827-70: N, E.
Escherichia coli ETEC H10407: N, E.
Escherichia coli 2362-75: N, E.
Escherichia coli O83:H1 str. NRG 857C: N, E.
Escherichia coli MS 110-3: N, E.
Escherichia coli MS 153-1: N, E.
Escherichia coli MS 16-3: N, E.
Escherichia coli 3431: N, E.
Escherichia coli MS 85-1: N, E.
Escherichia coli O157:H7 str. G5101: N, E.
Escherichia coli O157:H7: N, E.
Escherichia coli O6: N, E.
Escherichia coli MS 84-1: N, E.
Escherichia coli 96.154: N, E.
Escherichia coli DEC7B: N, E.
Escherichia coli DEC3E: N, E.
Escherichia coli 907446: N, E.
Escherichia coli E1167: N, E.
Escherichia coli BWH 34: N, E.
Escherichia coli H730: N, E.
Escherichia coli DEC13D: N, E.
Escherichia coli HVH 78 (4-2735946): N, E.
Escherichia coli UMEA 4075-1: N, E.
Escherichia coli STEC_S1191: N, E.
Escherichia coli 97.0246: N, E.
Escherichia coli TA206: N, E.
Escherichia coli HVH 177 (4-2876612): N, E.
Escherichia coli str. 'clone D i2': N, E.
Escherichia coli DEC3A: N, E.
Escherichia coli KTE25: N, E.
Escherichia coli DEC10A: N, E.
Escherichia coli 95.0183: N, E.
Escherichia coli O25b:H4-ST131 str. EC958: N, E.
Escherichia coli 3.2303: N, E.
Escherichia coli HVH 90 (4-3191362): N, E.
Escherichia coli KTE106: N, E.
Escherichia coli KTE173: N, E.
Escherichia coli HVH 115 (4-4465989): N, E.
Escherichia coli MS 60-1: N, E.
Escherichia coli KTE15: N, E.
Escherichia coli DEC7E: N, E.
Escherichia coli STEC_EH250: N, E.
Escherichia coli 907700: N, E.
Escherichia coli DEC10C: N, E.
Escherichia coli KTE215: N, E.
Escherichia coli 3030-1: N, E.
Escherichia coli DEC15B: N, E.
Escherichia coli KTE162: N, E.
Escherichia coli DEC3D: N, E.
Escherichia coli KTE186: N, E.
Escherichia coli 93.0624: N, E.
Escherichia coli TW10509: N, E.
Escherichia coli DEC9E: N, E.
Escherichia coli 1.2264: N, E.
Escherichia coli KTE43: N, E.
Escherichia coli B41: N, E.
Escherichia coli DEC11B: N, E.
Escherichia coli UMEA 3244-1: N, E.
Escherichia coli 908632: N, E.
Escherichia coli DEC13C: N, E.
Escherichia coli DEC5E: N, E.
Escherichia coli TW07793: N, E.
Escherichia coli H494: N, E.
Escherichia coli DEC2A: N, E.
Escherichia coli H397: N, E.
Escherichia coli DEC3F: N, E.
Escherichia coli HVH 138 (4-6066704): N, E.
Escherichia coli IS35: N, E.
Escherichia coli 9.0111: N, E.
Escherichia coli DEC7C: N, E.
Escherichia coli STEC_H.1.8: N, E.
Escherichia coli DEC2D: N, E.
Escherichia coli KTE89: N, E.
Escherichia coli 99.0848: N, E.
Escherichia coli HVH 202 (4-3163997): N, E.
Escherichia coli 4.0522: N, E.
Escherichia coli 5.0959: N, E.
Escherichia coli O55:H7 str. RM12579: N, E.
Escherichia coli CFT073: N, E.
Escherichia coli DEC8C: N, E.
Escherichia coli DEC3C: N, E.
Escherichia coli KTE169: N, E.
Escherichia coli CB7326: N, E.
Escherichia coli O104:H4 str. 01-09591: N, E.
Escherichia coli O157:H7 str. 1125: N, E.
Escherichia coli SCI-07: N, E.
Escherichia coli DEC10E: N, E.
Escherichia coli TA007: N, E.
Escherichia coli 2534-86: N, E.
Escherichia coli 3.3884: N, E.
Escherichia coli DEC6B: N, E.
Escherichia coli O104:H4 str. 11-4522: N, E.
Escherichia coli KTE16: N, E.
Escherichia coli KTE195: N, E.
Escherichia coli 0.1288: N, E.
Escherichia coli O104:H4 str. LB226692: N, E.
Escherichia coli ISC41: N, E.
Escherichia coli G58-1: N, E.
Escherichia coli DEC11D: N, E.
Escherichia coli O157:H7 str. 1044: N, E.
Escherichia coli UMEA 3108-1: N, E.
Escherichia coli 900105 (10e): N, E.
Escherichia coli 2.3916: N, E.
Escherichia coli DEC9D: N, E.
Escherichia coli AA86: N, E.
Escherichia coli O104:H4 str. 11-4623: N, E.
Escherichia coli DEC1A: N, E.
Escherichia coli DEC14B: N, E.
Escherichia coli TA271: N, E.
Escherichia coli TA124: N, E.
Escherichia coli DEC14C: N, E.
Escherichia coli HVH 176 (4-3428664): N, E.
Escherichia coli HVH 24 (4-5985145): N, E.
Escherichia coli XH001: N, E.
Escherichia coli HVH 141 (4-5995973): N, E.
Escherichia coli HVH 4 (4-7276109): N, E.
Escherichia coli KTE28: N, E.
Escherichia coli DEC4C: N, E.
Escherichia coli DEC8B: N, E.
Escherichia coli E101: N, E.
Escherichia coli KTE145: N, E.
Escherichia coli DEC4B: N, E.
Escherichia coli DEC8D: N, E.
Escherichia coli EC1868: N, E.
Escherichia coli DEC15A: N, E.
Escherichia coli DEC2E: N, E.
Escherichia coli KTE133: N, E.
Escherichia coli IS29: N, E.
Escherichia coli HVH 108 (4-6924867): N, E.
Escherichia coli DEC12B: N, E.
Escherichia coli TA143: N, E.
Escherichia coli H120: N, E.
Escherichia coli KTE207: N, E.
Escherichia coli AI27: N, E.
Escherichia coli Bd5610_99: N, E.
Escherichia coli KTE216: N, E.
Escherichia coli DEC12D: N, E.
Escherichia coli DEC13A: N, E.
Escherichia coli KTE93: N, E.
Escherichia coli KTE102: N, E.
Escherichia coli DEC2C: N, E.
Escherichia coli UMNF18: N, E.
Escherichia coli DEC10B: N, E.
Escherichia coli HVH 21 (4-4517873): N, E.
Escherichia coli UMEA 3155-1: N, E.
Escherichia coli EC4437: N, E.
Escherichia coli HVH 17 (4-7473087): N, E.
Escherichia coli 5.0588: N, E.
Escherichia coli O104:H4 str. 11-4632 C2: N, E.
Escherichia coli KTE88: N, E.
Escherichia coli HVH 162 (4-5627982): N, E.
Escherichia coli KTE211: N, E.
Escherichia coli B093: N, E.
Escherichia coli 3.2608: N, E.
Escherichia coli STEC_MHI813: N, E.
Escherichia coli JJ1886: N, E.
Escherichia coli NE1487: N, E.
Escherichia coli DEC5B: N, E.
Escherichia coli DEC11E: N, E.
Escherichia coli KTE109: N, E.
Escherichia coli B799: N, E.
Escherichia coli STEC_7v: N, E.
Escherichia coli O104:H4 str. 11-4632 C5: N, E.
Escherichia coli DEC15D: N, E.
Escherichia coli DEC9B: N, E.
Escherichia coli DEC6C: N, E.
Escherichia coli KTE175: N, E.
Escherichia coli KTE18: N, E.
Escherichia coli 1.2741: N, E.
Escherichia coli KTE168: N, E.
Escherichia coli DEC15C: N, E.
Escherichia coli 908624: N, E.
Escherichia coli BIDMC 20B: N, E.
Escherichia coli STEC_DG131-3: N, E.
Escherichia coli DEC8E: N, E.
Escherichia coli DEC15E: N, E.
Escherichia coli LAU-EC7: N, E.
Escherichia coli W26: N, E.
Escherichia coli DEC13E: N, E.
Escherichia coli O104:H4 str. C236-11: N, E.
Escherichia coli KTE183: N, E.
Escherichia coli 907779: N, E.
Escherichia coli TW14313: N, E.
Escherichia coli E1520: N, E.
Escherichia coli KTE23: N, E.
Escherichia coli KTE139: N, E.
Escherichia coli MS 57-2: N, E.
Escherichia coli KTE49: N, E.
Escherichia coli O7:K1 str. CE10: N, E.
Escherichia coli J53: N, E.
Escherichia coli 96.0497: N, E.
Escherichia coli O104:H4 str. 11-3677: N, E.
Escherichia coli H263: N, E.
Escherichia coli BIDMC 38: N, E.
Escherichia coli DEC14D: N, E.
Escherichia coli M605: N, E.
Escherichia coli KTE191: N, E.
Escherichia coli BWH 24: N, E.
Escherichia coli STEC_94C: N, E.
Escherichia coli UMEA 3193-1: N, E.
Escherichia coli KTE150: N, E.
Escherichia coli DEC4A: N, E.
Escherichia coli UMEA 3391-1: N, E.
Escherichia coli DEC12C: N, E.
Escherichia coli KTE86: N, E.
Escherichia coli KTE189: N, E.
Escherichia coli B49-2: N, E.
Escherichia coli HVH 38 (4-2774682): N, E.
Escherichia coli DEC7D: N, E.
Escherichia coli HVH 205 (4-3094677): N, E.
Escherichia coli M718: N, E.
Escherichia coli H591: N, E.
Escherichia coli 908691: N, E.
Escherichia coli 2-005-03_S4_C2: N, E.
Escherichia coli HVH 111 (4-7039018): N, E.
Escherichia coli DEC5C: N, E.
Escherichia coli KTE6: N, E.
Escherichia coli BIDMC 20A: N, E.
Escherichia coli JB1-95: N, E.
Escherichia coli DEC9A: N, E.
Escherichia coli DEC6E: N, E.
Escherichia coli O104:H4 str. 11-4632 C3: N, E.
Escherichia coli DEC11C: N, E.
Escherichia coli O104:H4 str. 04-8351: N, E.
Escherichia coli 907701: N, E.
Escherichia coli cloneA_i1: N, E.
Escherichia coli DEC6D: N, E.
Escherichia coli O32:H37 str. P4: N, E.
Escherichia coli DEC1C: N, E.
Escherichia coli DEC10D: N, E.
Escherichia coli DEC7A: N, E.
Escherichia coli KTE192: N, E.
Escherichia coli DEC12E: N, E.
Escherichia coli H252: N, E.
Escherichia coli DEC4F: N, E.
Escherichia coli DEC6A: N, E.
Escherichia coli O104:H4 str. 09-7901: N, E.
Escherichia coli UMEA 3693-1: N, E.
Escherichia coli HVH 146 (4-3189767): N, E.
Escherichia coli KTE194: N, E.
Escherichia coli 2.4168: N, E.
Escherichia coli H736: N, E.
Escherichia coli KTE104: N, E.
Escherichia coli DEC2B: N, E.
Escherichia coli UMEA 3805-1: N, E.
Escherichia coli HVH 154 (4-5636698): N, E.
Escherichia coli DEC13B: N, E.
Escherichia coli DEC3B: N, E.
Escherichia coli O104:H4 str. 11-4632 C1: N, E.
Escherichia coli HVH 171 (4-3191958): N, E.
Escherichia coli HVH 186 (4-3405044): N, E.
Escherichia coli 908524: N, E.
Escherichia coli KTE70: N, E.
Escherichia coli DEC5D: N, E.
Escherichia coli O104:H4 str. 11-4632 C4: N, E.
Escherichia coli DEC1D: N, E.
Escherichia coli H489: N, E.
Shigella sp. D9: N, E.
Escherichia coli 3003: N, E.
Escherichia coli O81:NM str. 02-3012: N, E.
Escherichia coli DEC8A: N, E.
Escherichia coli O104:H4 str. C227-11: N, E.
Escherichia coli DEC14A: N, E.
Escherichia coli KTE17: N, E.
Escherichia coli TX1999: N, E.
Escherichia coli 4.0967: N, E.
Escherichia coli DEC11A: N, E.
Escherichia coli UMNK88: N, E.
Escherichia coli STEC_B2F1: N, E.
Escherichia coli ECC-1470: N, E.
Escherichia coli UMEA 3185-1: N, E.
Escherichia coli STEC_C165-02: N, E.
Escherichia coli KTE224: N, E.
Escherichia coli DEC10F: N, E.
Escherichia coli DEC4E: N, E.
Escherichia coli E482: N, E.
Escherichia coli KTE217: N, E.
Escherichia coli HVH 143 (4-5674999): N, E.
Escherichia coli DEC1E: N, E.
Escherichia coli O104:H21 str. CFSAN002236: N, E.
Escherichia coli 4_1_47FAA: N, E.
Escherichia coli DEC5A: N, E.
Escherichia coli UMEA 3955-1: N, E.
Escherichia coli Xuzhou21: N, E.
Escherichia coli HVH 228 (4-7787030): N, E.
Escherichia coli str. K-12 substr. MDS42: N, E.
Escherichia coli KTE72: N, E.
Escherichia coli DEC12A: N, E.
Escherichia coli H299: N, E.
Escherichia coli KTE148: N, E.
Escherichia coli CAG:4: N, E.
Escherichia coli HVH 84 (4-1021478): N, E.
Escherichia coli BIDMC 83: N, E.
Escherichia coli PCN033: N, E.
Escherichia coli HVH 197 (4-4466217): N, E.
Escherichia coli DEC4D: N, E.
Escherichia coli MS 117-3: N, E.
Escherichia coli M863: N, E.
Escherichia coli KTE75: N, E.
Escherichia coli KTE113: N, E.
Escherichia coli O104:H4 str. 11-4404: N, E.
Escherichia coli DEC1B: N, E.
Escherichia coli KTE178: N, E.
Escherichia coli O104:H21 str. 94-3025: N, E.
Escherichia coli 2-005-03_S4_C3: N, E.
Escherichia coli DEC9C: N, E.
Escherichia coli str. 'clone D i14': N, E.
Escherichia coli O139:H28 str. E24377A: N, E.
Escherichia coli OK1357: N, E.
Escherichia coli OK1180: N, E.
Escherichia coli KOEGE 61 (174a): N, E.
Escherichia coli HVH 33 (4-2174936): N, E.
Escherichia coli KTE98: N, E.
Escherichia coli TW09098: N, E.
Escherichia coli M919: N, E.
Escherichia coli HVH 79 (4-2512823): N, E.
Escherichia coli SEPT362: N, E.
Escherichia coli O08: N, E.
Escherichia coli ISC56: N, E.
Escherichia coli D9: N, E.
Escherichia coli ISC11: N, E.
Escherichia coli 1-176-05_S3_C2: N, E.
Escherichia coli O145:H28 str. RM12581: N, E.
Escherichia coli O145:NM str. 2010C-3526: N, E.
Escherichia coli UCI 65: N, E.
Escherichia coli 5-366-08_S1_C3: N, E.
Escherichia coli 5-366-08_S1_C1: N, E.
Escherichia coli 1-250-04_S3_C2: N, E.
Escherichia coli UMEA 3162-1: N, E.
Escherichia coli O157:H7 str. SS52: N, E.
Escherichia coli APEC O18: N, E.
Escherichia coli N37122PS: N, E.
Escherichia coli N37139PS: N, E.
Escherichia coli N36410PS: N, E.
Escherichia coli M056: N, E.
Escherichia coli TA447: N, E.
Escherichia coli H461: N, E.
Escherichia coli H605: N, E.
Escherichia coli TA054: N, E.
Escherichia coli TA249: N, E.
Escherichia coli KTE21: N, E.
Escherichia coli KTE76: N, E.
Escherichia coli KTE146: N, E.
Escherichia coli 3.4880: N, E.
Escherichia coli KTE20: N, E.
Escherichia coli KTE182: N, E.
Escherichia coli HVH 25 (4-5851939): N, E.
Escherichia coli HVH 41 (4-2677849): N, E.
Escherichia coli HVH 70 (4-2963531): N, E.
Escherichia coli UMEA 3200-1: N, E.
Escherichia coli UMEA 3718-1: N, E.
Escherichia coli 113290: N, E.
Escherichia coli 110957: N, E.
Escherichia coli 907713: N, E.
Escherichia coli 907672: N, E.
Escherichia coli 908519: N, E.
Escherichia coli 908525: N, E.
Escherichia coli 908573: N, E.
Escherichia coli UMEA 3323-1: N, E.
Escherichia coli 97.0259: N, E.
Escherichia coli LAU-EC10: N, E.
Escherichia coli 1-182-04_S3_C3: N, E.
Escherichia coli 3-373-03_S4_C2: N, E.
Escherichia coli 2-011-08_S1_C1: N, E.
Escherichia coli M114: N, E.
Escherichia coli TA280: N, E.
Escherichia coli KTE66: N, E.
Escherichia coli DORA_A_5_14_21: N, E.
Escherichia coli D6-113.11: N, E.
Escherichia coli O174:H8 str. 04-3038: N, E.
Escherichia coli O111:NM str. K6722: N, E.
Escherichia coli O69:H11 str. 08-4661: N, E.
Escherichia coli O118:H16 str. 2009C-4446: N, E.
Escherichia coli O26:H11: N, E.
Escherichia coli O121:H19 str. 2010C-3609: N, E.
Escherichia coli N36254PS: N, E.
Escherichia coli SHECO001: N, E.
Escherichia coli H420: N, E.
Escherichia coli O111:H8 str. CVM9634: N, E.
Escherichia coli O111:H11 str. CVM9455: N, E.
Escherichia coli KTE193: N, E.
Escherichia coli KTE112: N, E.
Escherichia coli KTE64: N, E.
Escherichia coli KTE100: N, E.
Escherichia coli 99.0741: N, E.
Escherichia coli ATCC BAA-2209: N, E.
LegendThis sequence has been compared to family alignement (MSA) red => minority aminoacid blue => majority aminoacid color intensity => conservation rate title => sequence position(MSA position)aminoacid rate Catalytic site Catalytic site in the MSA MYAREYRSTRPHKAIFFHLSCLTLICSAQVYAEPDMRPLGPNIADKGSVF YHFSTTSFDSVDGTRHYRVWTAVPNTTAPASGYPILYMLDGNAVMDRLDD ELLKQLSEKTPPVIVAVGYQTNLPFDLNSRAYDYTPAAESRKTDLHSGRF SRKSGGSNNFRQLLETRIAPKVEQGLNIDRQRRGLWGHSYGGLFVLDSWL SSSYFRSYYSASPSLGRGYDALLSRVTAVEPLQFCAKHLAIMEGSATQGD NRETHAVGVLSKIHTTLTILKDKGVNVVFWDFPNLGHGPMFNASFRQALL DISGENANYTAGCHELSH
The proliferation of many pathogenic bacteria is limited by the scarcity of soluble iron in their environment. Many of these bacteria scavenge iron by synthesizing and exporting small molecule siderophores that chelate iron. Iron-bound siderophores are subsequently imported for metabolic processing. Three related serine hydrolases have been characterized biochemically in this pathway: Fes, IroD, and IroE. Here, we report the crystal structure of IroE from uropathogenic Escherichia coli CFT073. The native structure and a complex with diisopropyl fluorophosphonate (DFP, a potent serine hydrolase inhibitor) were determined at 2.3 and 1.4 A resolution, respectively. IroE has the typical alpha/beta-hydrolase fold with an atypical catalytic dyad composed of Ser 189 and His 287. Mutation of either residue was detrimental to catalysis. In addition, rather than the typical oxyanion hole composed of backbone amides, IroE employs the atypical guanidinium moiety of Arg 130. Asp 90 anchors Arg 130 in the active site, and mutation of either residue was likewise detrimental to catalysis. We also compare the structure of IroE to the structure of Fes from Shigella flexneri (PDB entry 2B20). Both enzymes have similar active sites, but Fes has an additional amino-terminal lid domain. These lid domains are proposed to confer specificity to these related hydrolases.
Nonpathogenic Escherichia coli strain Nissle 1917 (O6:K5:H1) is used as a probiotic agent in medicine, mainly for the treatment of various gastroenterological diseases. To gain insight on the genetic level into its properties of colonization and commensalism, this strain's genome structure has been analyzed by three approaches: (i) sequence context screening of tRNA genes as a potential indication of chromosomal integration of horizontally acquired DNA, (ii) sequence analysis of 280 kb of genomic islands (GEIs) coding for important fitness factors, and (iii) comparison of Nissle 1917 genome content with that of other E. coli strains by DNA-DNA hybridization. PCR-based screening of 324 nonpathogenic and pathogenic E. coli isolates of different origins revealed that some chromosomal regions are frequently detectable in nonpathogenic E. coli and also among extraintestinal and intestinal pathogenic strains. Many known fitness factor determinants of strain Nissle 1917 are localized on four GEIs which have been partially sequenced and analyzed. Comparison of these data with the available knowledge of the genome structure of E. coli K-12 strain MG1655 and of uropathogenic E. coli O6 strains CFT073 and 536 revealed structural similarities on the genomic level, especially between the E. coli O6 strains. The lack of defined virulence factors (i.e., alpha-hemolysin, P-fimbrial adhesins, and the semirough lipopolysaccharide phenotype) combined with the expression of fitness factors such as microcins, different iron uptake systems, adhesins, and proteases, which may support its survival and successful colonization of the human gut, most likely contributes to the probiotic character of E. coli strain Nissle 1917.
We present the complete genome sequence of uropathogenic Escherichia coli, strain CFT073. A three-way genome comparison of the CFT073, enterohemorrhagic E. coli EDL933, and laboratory strain MG1655 reveals that, amazingly, only 39.2% of their combined (nonredundant) set of proteins actually are common to all three strains. The pathogen genomes are as different from each other as each pathogen is from the benign strain. The difference in disease potential between O157:H7 and CFT073 is reflected in the absence of genes for type III secretion system or phage- and plasmid-encoded toxins found in some classes of diarrheagenic E. coli. The CFT073 genome is particularly rich in genes that encode potential fimbrial adhesins, autotransporters, iron-sequestration systems, and phase-switch recombinases. Striking differences exist between the large pathogenicity islands of CFT073 and two other well-studied uropathogenic E. coli strains, J96 and 536. Comparisons indicate that extraintestinal pathogenic E. coli arose independently from multiple clonal lineages. The different E. coli pathotypes have maintained a remarkable synteny of common, vertically evolved genes, whereas many islands interrupting this common backbone have been acquired by different horizontal transfer events in each strain.
        
20 lessTitle: Draft Genome Sequences of Extended-Spectrum beta-Lactamase-Producing Escherichia coli Strains Isolated from Patients in Lebanon Tokajian S, Eisen JA, Jospin G, Farra A, Coil DA Ref: Genome Announc, 2:, 2014 : PubMed
We present the draft genome sequences of nine extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strains isolated from stool samples collected from patients admitted for gastrointestinal and urological procedures/surgeries. An average of 3,889,300 paired-end reads per sample were generated, which assembled in 77 to 157 contigs.
        
Title: Nucleotide sequences of 16 transmissible plasmids identified in nine multidrug-resistant Escherichia coli isolates expressing an ESBL phenotype isolated from food-producing animals and healthy humans Wang J, Stephan R, Power K, Yan Q, Hachler H, Fanning S Ref: J Antimicrob Chemother, 69:2658, 2014 : PubMed
OBJECTIVES: Nine extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from healthy humans and food-producing animals were found to transfer their cefotaxime resistance marker at high frequency in laboratory conjugation experiments. The objective of this study was to completely characterize 16 transmissible plasmids that were detected in these bacterial isolates. METHODS: The nucleotide sequences of all 16 plasmids were determined from transconjugants using next-generation sequencing technology. Open reading frames were assigned using Rapid Annotation using Subsystem Technology and analysed by BLASTn and BLASTp. The standard method was used for plasmid multilocus sequence typing (pMLST) analysis. Plasmid structures were subsequently confirmed by PCR amplification of selected regions. RESULTS: The complete circularized nucleotide sequence of 14 plasmids was determined, along with that of a further two plasmids that could not be confirmed as closed. These ranged in size from 1.8 to 166.6 kb. Incompatibility groups and pMLSTs identified included IncI1/ST3, IncI1/ST36, IncN/ST1, IncF and IncB/O, and those of the same Inc types presented a similar backbone structure despite being isolated from different sources. Eight plasmids contained bla(CTX-M-1) genes that were associated with either ISEcp1 or IS26 insertion sequence elements. Six plasmids isolated from humans and chickens were identical or closely related to the IncI1 reference plasmid, R64. CONCLUSIONS: These data, based on comparative sequence analysis, highlight the successful spread of blaESBL-harbouring plasmids of different Inc types among isolates of human and food-producing animal origin and provide further evidence for potential dissemination routes.
        
Title: Draft Genome Sequence of Uropathogenic Escherichia coli Strain J96 Klein EA, Gitai Z Ref: Genome Announc, 1:, 2013 : PubMed
Escherichia coli J96 (O4:K6) was isolated from a human pyelonephritis patient. Here, we report the draft genome sequence of E. coli J96, which contains virulence genes, including adhesion factors, alpha-hemolysins, and cytotoxic necrotizing factor. J96 infects the kidney and bladder, making it an important tool for studying E. coli pathogenesis.
Recent isolation of the non-K1 Escherichia coli neonatal meningitis strain S286, belonging to phylogroup C, which is closely related to major group B1, and producing an extended-spectrum beta-lactamase, encouraged us to seek the genetic determinants responsible for its virulence. We show that S286 belongs to the sequence O type ST23O78 and harbors 4 large plasmids. The largest one, pS286colV (~120 kb), not related to resistance, contains genes characteristic of a Conserved Virulence Plasmidic (CVP) region initially identified in B2 extra-intestinal avian pathogenic E. coli (APEC) strains and in the B2 neonatal meningitis E. coli strain S88. The sequence of this CVP region has a strong homology (98%) with that of the recently sequenced plasmid pChi7122-1 of the O78 APEC strain Chi7122. A CVP plasmid-cured variant of S286 was less virulent than the wild type strain in a neonatal rat sepsis model with a significant lower level of bacteremia at 24 h (4.1 +/- 1.41 versus 2.60 +/- 0.16 log CFU/ml, p = 0.001) and mortality. However, the mortality in the model of adult mice was comparable between wild type and variant indicating that pS286colV is not sufficient by itself to fully explain the virulence of S286. Gene expression analysis of pS286colV in iron depleted environment was very close to that of pS88, suggesting that genes of CVP region may be expressed similarly in two very different genetic backgrounds (group C versus group B2). Screening a collection of 178 human A/B1 extraintestinal pathogenic E. coli (ExPEC) strains revealed that the CVP region is highly prevalent (23%) and MLST analysis indicated that these CVP positive strains belong to several clusters and mostly to phylogroup C. The virulence of S286 is explained in part by the presence of CVP region and this region has spread in different clusters of human A/B1 ExPEC, especially in group C.
Avian pathogenic Escherichia coli (APEC) infections are responsible for significant losses in the poultry industry worldwide. The disease might present as different local infections or as septicemia. Here, we present the draft genome sequences of three Brazilian APEC strains isolated from different kinds of infections. The availability of these APEC genome sequences is important for gaining a thorough understanding of the genomic features of E. coli, particularly those of this pathotype.
        
Title: Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain Zong Z Ref: Antimicrobial Agents & Chemotherapy, 57:597, 2013 : PubMed
The complete sequence of a 137-kb plasmid, pJIE186-2, from a sequence type 131 (ST131) Escherichia coli strain was determined. pJIE186-2 contained IncF replicons (FIB, FIIA, and FIADelta), an incomplete conjugative region, and multiple virulence factors (sitABCD, iucABCD-iutA, iroCDEN, etsABC, hlyF, iss, ompT, and vagCD) but no antimicrobial resistance genes. The host strain also had another plasmid, pJIE186-1, carrying multiple resistance genes. The two plasmids conferred selective advantages for the host strain, contributing to the recent emergence of ST131 E. coli.
Avian-pathogenic Escherichia coli (APEC) strains cause extraintestinal diseases in avian species. Here, we present the draft genome of an APEC strain (SCI-07) from Brazil that was isolated from skin lesions (gelatinous edema) on the head and periorbital tissues of a laying hen with swollen head syndrome.
        
Title: Complete genome sequence of adherent invasive Escherichia coli UM146 isolated from Ileal Crohn's disease biopsy tissue Krause DO, Little AC, Dowd SE, Bernstein CN Ref: Journal of Bacteriology, 193:583, 2011 : PubMed
Escherichia coli UM146 was isolated from the ileum of a Crohn's disease patient. It adheres to and invades enterocytes and can replicate inside macrophages. Its complete genome sequence reveals that it is most closely related to the human urinary tract pathogen E. coli CFT073, but it has a host of genes that are novel and to which no function has been ascribed.
Extraintestinal pathogenic Escherichia coli (ExPEC) is an important pathogen which can infect humans and animals and cause many diseases outside the intestine. Here, we report the first draft genome sequence of a porcine ExPEC strain, PCN033, isolated from a pig with meningitis.
ColV plasmids of extraintestinal pathogenic Escherichia coli (ExPEC) encode a variety of fitness and virulence factors and have long been associated with septicemia and avian colibacillosis. These plasmids are found significantly more often in ExPEC, including ExPEC associated with human neonatal meningitis and avian colibacillosis, than in commensal E. coli. Here we describe pAPEC-O103-ColBM, a hybrid RepFIIA/FIB plasmid harboring components of the ColV pathogenicity island and a multidrug resistance (MDR)-encoding island. This plasmid is mobilizable and confers the ability to cause septicemia in chickens, the ability to cause bacteremia resulting in meningitis in the rat model of human disease, and the ability to resist the killing effects of multiple antimicrobial agents and human serum. The results of a sequence analysis of this and other ColV plasmids supported previous findings which indicated that these plasmid types arose from a RepFIIA/FIB plasmid backbone on multiple occasions. Comparisons of pAPEC-O103-ColBM with other sequenced ColV and ColBM plasmids indicated that there is a core repertoire of virulence genes that might contribute to the ability of some ExPEC strains to cause high-level bacteremia and meningitis in a rat model. Examination of a neonatal meningitis E. coli (NMEC) population revealed that approximately 58% of the isolates examined harbored ColV-type plasmids and that 26% of these plasmids had genetic contents similar to that of pAPEC-O103-ColBM. The linkage of the ability to confer MDR and the ability contribute to multiple forms of human and animal disease on a single plasmid presents further challenges for preventing and treating ExPEC infections.
Salmonella enterica continues to be a significant cause of foodborne gastrointestinal illness in humans. A wide variety of Salmonella serovars have been isolated from production birds and from retail poultry meat. Recently, though, S. enterica subsp. enterica serovar Kentucky has emerged as one of the prominent Salmonella serovars isolated from broiler chickens. Recent work suggests that its emergence apparently coincides with its acquisition of a ColV virulence plasmid. In the present study, we examined 902 Salmonella isolates belonging to 59 different serovars for the presence of this plasmid. Of the serovars examined, the ColV plasmid was found only among isolates belonging to the serovars Kentucky (72.9%), Typhimurium (15.0%) and Heidelberg (1.7%). We demonstrated that a single PFGE clonal type of S. Kentucky harbors this plasmid, and acquisition of this plasmid by S. Kentucky significantly increased its ability to colonize the chicken cecum and cause extraintestinal disease. Comparison of the completed sequences of three ColV plasmids from S. Kentucky isolated from different geographical locales, timepoints and sources revealed a nearly identical genetic structure with few single nucleotide changes or insertions/deletions. Overall, it appears that the ColV plasmid was recently acquired by a single clonal type S. Kentucky and confers to its host enhanced colonization and fitness capabilities. Thus, the potential for horizontal gene transfer of virulence and fitness factors to Salmonella from other enteric bacteria exists in poultry, representing a potential human health hazard.
Extraintestinal pathogenic Escherichia coli (ExPEC) are a common cause of disease in both mammals and birds. A vaccine to prevent such infections would be desirable given the increasing antibiotic resistance of these bacteria. We have determined the genome sequence of ExPEC IHE3034 (ST95) isolated from a case of neonatal meningitis and compared this to available genome sequences of other ExPEC strains and a few nonpathogenic E. coli. We found 19 genomic islands present in the genome of IHE3034, which are absent in the nonpathogenic E. coli isolates. By using subtractive reverse vaccinology we identified 230 antigens present in ExPEC but absent (or present with low similarity) in nonpathogenic strains. Nine antigens were protective in a mouse challenge model. Some of them were also present in other pathogenic non-ExPEC strains, suggesting that a broadly protective E. coli vaccine may be possible. The gene encoding the most protective antigen was detected in most of the E. coli isolates, highly conserved in sequence and found to be exported by a type II secretion system which seems to be nonfunctional in nonpathogenic strains.
        
Title: The conserved portion of the putative virulence region contributes to virulence of avian pathogenic Escherichia coli Tivendale KA, Noormohammadi AH, Allen JL, Browning GF Ref: Microbiology, 155:450, 2009 : PubMed
Colibacillosis is a common systemic disease of worldwide economic importance in poultry, caused by Escherichia coli. E. coli are normally found in the intestines of poultry, but some strains are able to cause extraintestinal disease. Plasmid pVM01 is essential for virulence in avian pathogenic Escherichia coli (APEC) strain E3 in chickens after aerosol exposure and contains the virulence-associated genes iucA, iss and tsh in distinct regions. The determination of the complete sequence of this plasmid identified many ORFs that were highly similar to genes found in the APEC O1 plasmid, as well as many hypothetical ORFs. Truncated versions of pVM01 were constructed and introduced into avirulent APEC strain E3/2.4 and the pathogenicity of these strains was assessed by aerosol exposure. The function of the region of pVM01 that contains the genes for conjugation was confirmed. Strains carrying the truncated plasmids appeared to be of intermediate virulence compared to the wild-type APEC strain E3. The conserved portion of the putative virulence region was found to contribute to the colonization of and generation of lesions in the air sacs. Both the conserved and variable portions of the putative virulence region were shown to contribute to the colonization of the trachea, but the variable portion of the putative virulence region was not required for the strain to confer a virulent phenotype. These results reveal that deletion of the conserved portion of the putative virulence region, but not the variable portion of the putative virulence region, is associated with a decrease in virulence of APEC.
The Escherichia coli species represents one of the best-studied model organisms, but also encompasses a variety of commensal and pathogenic strains that diversify by high rates of genetic change. We uniformly (re-) annotated the genomes of 20 commensal and pathogenic E. coli strains and one strain of E. fergusonii (the closest E. coli related species), including seven that we sequenced to completion. Within the approximately 18,000 families of orthologous genes, we found approximately 2,000 common to all strains. Although recombination rates are much higher than mutation rates, we show, both theoretically and using phylogenetic inference, that this does not obscure the phylogenetic signal, which places the B2 phylogenetic group and one group D strain at the basal position. Based on this phylogeny, we inferred past evolutionary events of gain and loss of genes, identifying functional classes under opposite selection pressures. We found an important adaptive role for metabolism diversification within group B2 and Shigella strains, but identified few or no extraintestinal virulence-specific genes, which could render difficult the development of a vaccine against extraintestinal infections. Genome flux in E. coli is confined to a small number of conserved positions in the chromosome, which most often are not associated with integrases or tRNA genes. Core genes flanking some of these regions show higher rates of recombination, suggesting that a gene, once acquired by a strain, spreads within the species by homologous recombination at the flanking genes. Finally, the genome's long-scale structure of recombination indicates lower recombination rates, but not higher mutation rates, at the terminus of replication. The ensuing effect of background selection and biased gene conversion may thus explain why this region is A+T-rich and shows high sequence divergence but low sequence polymorphism. Overall, despite a very high gene flow, genes co-exist in an organised genome.
Escherichia coli is a model laboratory bacterium, a species that is widely distributed in the environment, as well as a mutualist and pathogen in its human hosts. As such, E. coli represents an attractive organism to study how environment impacts microbial genome structure and function. Uropathogenic E. coli (UPEC) must adapt to life in several microbial communities in the human body, and has a complex life cycle in the bladder when it causes acute or recurrent urinary tract infection (UTI). Several studies designed to identify virulence factors have focused on genes that are uniquely represented in UPEC strains, whereas the role of genes that are common to all E. coli has received much less attention. Here we describe the complete 5,065,741-bp genome sequence of a UPEC strain recovered from a patient with an acute bladder infection and compare it with six other finished E. coli genome sequences. We searched 3,470 ortholog sets for genes that are under positive selection only in UPEC strains. Our maximum likelihood-based analysis yielded 29 genes involved in various aspects of cell surface structure, DNA metabolism, nutrient acquisition, and UTI. These results were validated by resequencing a subset of the 29 genes in a panel of 50 urinary, periurethral, and rectal E. coli isolates from patients with UTI. These studies outline a computational approach that may be broadly applicable for studying strain-specific adaptation and pathogenesis in other bacteria.
The genome of uropathogenic Escherichia coli isolate 536 contains five well-characterized pathogenicity islands (PAIs) encoding key virulence factors of this strain. Except PAI IV(536), the four other PAIs of strain 536 are flanked by direct repeats (DRs), carry intact integrase genes and are able to excise site-specifically from the chromosome. Genome screening of strain 536 identified a sixth putative asnW-associated PAI. Despite the presence of DRs and an intact integrase gene, excision of this island was not detected. To investigate the role of PAI-encoded integrases for the recombination process the int genes of each unstable island of strain 536 were inactivated. For PAI I(536) and PAI II(536), their respective P4-like integrase was required for their excision. PAI III(536) carries two integrase genes, intA, encoding an SfX-like integrase, and intB, coding for an integrase with weak similarity to P4-like integrases. Only intB was required for site-specific excision of this island. For PAI V(536), excision could not be abolished after deleting its P4-like integrase gene but additional deletion of the PAI II(536)-specific integrase gene was required. Therefore, although all mediated by P4-like integrases, the activity of the PAI excision machinery is most often restricted to its cognate island. This work also demonstrates for the first time the existence of a cross-talk between integrases of different PAIs and shows that this cross-talk is unidirectional.
        
Title: Complete DNA sequence of a ColBM plasmid from avian pathogenic Escherichia coli suggests that it evolved from closely related ColV virulence plasmids Johnson TJ, Johnson SJ, Nolan LK Ref: Journal of Bacteriology, 188:5975, 2006 : PubMed
Avian pathogenic Escherichia coli (APEC), an extraintestinal pathogenic E. coli causing colibacillosis in birds, is responsible for significant economic losses for the poultry industry. Recently, we reported that the APEC pathotype was characterized by possession of a set of genes contained within a 94-kb cluster linked to a ColV plasmid, pAPEC-O2-ColV. These included sitABCD, genes of the aerobactin operon, hlyF, iss, genes of the salmochelin operon, and the 5' end of cvaB of the ColV operon. However, the results of gene prevalence studies performed among APEC isolates revealed that these traits were not always linked to ColV plasmids. Here, we present the complete sequence of a 174-kb plasmid, pAPEC-O1-ColBM, which contains a putative virulence cluster similar to that of pAPEC-O2-ColV. These two F-type plasmids share remarkable similarity, except that they encode the production of different colicins; pAPEC-O2-ColV contains an intact ColV operon, and pAPEC-O1-ColBM encodes the colicins B and M. Interestingly, remnants of the ColV operon exist in pAPEC-O1-ColBM, hinting that ColBM-type plasmids may have evolved from ColV plasmids. Among APEC isolates, the prevalence of ColBM sequences helps account for the previously observed differences in prevalence between genes of the "conserved" portion of the putative virulence cluster of pAPEC-O2-ColV and those genes within its "variable" portion. These results, in conjunction with Southern blotting and probing of representative ColBM-positive strains, indicate that this "conserved" cluster of putative virulence genes is primarily linked to F-type virulence plasmids among the APEC isolates studied.
The proliferation of many pathogenic bacteria is limited by the scarcity of soluble iron in their environment. Many of these bacteria scavenge iron by synthesizing and exporting small molecule siderophores that chelate iron. Iron-bound siderophores are subsequently imported for metabolic processing. Three related serine hydrolases have been characterized biochemically in this pathway: Fes, IroD, and IroE. Here, we report the crystal structure of IroE from uropathogenic Escherichia coli CFT073. The native structure and a complex with diisopropyl fluorophosphonate (DFP, a potent serine hydrolase inhibitor) were determined at 2.3 and 1.4 A resolution, respectively. IroE has the typical alpha/beta-hydrolase fold with an atypical catalytic dyad composed of Ser 189 and His 287. Mutation of either residue was detrimental to catalysis. In addition, rather than the typical oxyanion hole composed of backbone amides, IroE employs the atypical guanidinium moiety of Arg 130. Asp 90 anchors Arg 130 in the active site, and mutation of either residue was likewise detrimental to catalysis. We also compare the structure of IroE to the structure of Fes from Shigella flexneri (PDB entry 2B20). Both enzymes have similar active sites, but Fes has an additional amino-terminal lid domain. These lid domains are proposed to confer specificity to these related hydrolases.
        
Title: In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes Lin H, Fischbach MA, Liu DR, Walsh CT Ref: Journal of the American Chemical Society, 127:11075, 2005 : PubMed
The iroA locus encodes five genes (iroB, iroC, iroD, iroE, iroN) that are found in pathogenic Salmonella and Escherichia coli strains. We recently reported that IroB is an enterobactin (Ent) C-glucosyltransferase, converting the siderophore into mono-, di-, and triglucosyl enterobactins (MGE, DGE, and TGE, respectively). Here, we report the characterization of IroD and IroE as esterases for the apo and Fe(3+)-bound forms of Ent, MGE, DGE, and TGE, and we compare their activities with those of Fes, the previously characterized enterobactin esterase. IroD hydrolyzes both apo and Fe(3+)-bound siderophores distributively to generate DHB-Ser and/or Glc-DHB-Ser, with higher catalytic efficiencies (k(cat)/K(m)) on Fe(3+)-bound forms, suggesting that IroD is the ferric MGE/DGE esterase responsible for cytoplasmic iron release. Similarly, Fes hydrolyzes ferric Ent more efficiently than apo Ent, confirming Fes is the ferric Ent esterase responsible for Fe(3+) release from ferric Ent. Although each enzyme exhibits lower k(cat)'s processing ferric siderophores, dramatic decreases in K(m)'s for ferric siderophores result in increased catalytic efficiencies. The inability of Fes to efficiently hydrolyze ferric MGE, ferric DGE, or ferric TGE explains the requirement for IroD in the iroA cluster. IroE, in contrast, prefers apo siderophores as substrates and tends to hydrolyze the trilactone just once to produce linearized trimers. These data and the periplasmic location of IroE suggest that it hydrolyzes apo enterobactins while they are being exported. IroD hydrolyzes apo MGE (and DGE) regioselectively to give a single linear trimer product and a single linear dimer product as determined by NMR.
Nonpathogenic Escherichia coli strain Nissle 1917 (O6:K5:H1) is used as a probiotic agent in medicine, mainly for the treatment of various gastroenterological diseases. To gain insight on the genetic level into its properties of colonization and commensalism, this strain's genome structure has been analyzed by three approaches: (i) sequence context screening of tRNA genes as a potential indication of chromosomal integration of horizontally acquired DNA, (ii) sequence analysis of 280 kb of genomic islands (GEIs) coding for important fitness factors, and (iii) comparison of Nissle 1917 genome content with that of other E. coli strains by DNA-DNA hybridization. PCR-based screening of 324 nonpathogenic and pathogenic E. coli isolates of different origins revealed that some chromosomal regions are frequently detectable in nonpathogenic E. coli and also among extraintestinal and intestinal pathogenic strains. Many known fitness factor determinants of strain Nissle 1917 are localized on four GEIs which have been partially sequenced and analyzed. Comparison of these data with the available knowledge of the genome structure of E. coli K-12 strain MG1655 and of uropathogenic E. coli O6 strains CFT073 and 536 revealed structural similarities on the genomic level, especially between the E. coli O6 strains. The lack of defined virulence factors (i.e., alpha-hemolysin, P-fimbrial adhesins, and the semirough lipopolysaccharide phenotype) combined with the expression of fitness factors such as microcins, different iron uptake systems, adhesins, and proteases, which may support its survival and successful colonization of the human gut, most likely contributes to the probiotic character of E. coli strain Nissle 1917.
        
Title: Characterization of an iroBCDEN gene cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal transfer of a chromosomal virulence factor Sorsa LJ, Dufke S, Heesemann J, Schubert S Ref: Infect Immun, 71:3285, 2003 : PubMed
The chromosomal iroBCDEN gene cluster first described for Salmonella enterica is involved in the uptake of catecholate-type siderophore compounds. An orthologous gene cluster has recently been detected in Escherichia coli strains which cause extraintestinal disease. This E. coli iroBCDEN gene cluster has an impact on virulence and has been reported to be located in a pathogenicity island on the chromosome. In this study we characterized an iro gene cluster of a uropathogenic E. coli isolate which is located on a transmissible plasmid related to the R64 plasmid of S. enterica. This cluster is highly homologous to the chromosomal iro cluster of E. coli. When introduced into an E. coli fepA cir fiu aroB mutant, IroN, but not IroBCDE, mediated the utilization of structurally related catecholate siderophores, including 2,3-dihydroxybenzoyl-L-serine, 2,3-dihydroxybenzoyl-D-ornithine, 2,3-dihydroxybenzoic acid, and enterochelin. This study supports the idea of an ongoing horizontal transfer of putative virulence factors and the mobilization of single virulence gene clusters, which lead to a modular assembly of virulence determinants such as pathogenicity islands.
We present the complete genome sequence of uropathogenic Escherichia coli, strain CFT073. A three-way genome comparison of the CFT073, enterohemorrhagic E. coli EDL933, and laboratory strain MG1655 reveals that, amazingly, only 39.2% of their combined (nonredundant) set of proteins actually are common to all three strains. The pathogen genomes are as different from each other as each pathogen is from the benign strain. The difference in disease potential between O157:H7 and CFT073 is reflected in the absence of genes for type III secretion system or phage- and plasmid-encoded toxins found in some classes of diarrheagenic E. coli. The CFT073 genome is particularly rich in genes that encode potential fimbrial adhesins, autotransporters, iron-sequestration systems, and phase-switch recombinases. Striking differences exist between the large pathogenicity islands of CFT073 and two other well-studied uropathogenic E. coli strains, J96 and 536. Comparisons indicate that extraintestinal pathogenic E. coli arose independently from multiple clonal lineages. The different E. coli pathotypes have maintained a remarkable synteny of common, vertically evolved genes, whereas many islands interrupting this common backbone have been acquired by different horizontal transfer events in each strain.
The sfa(I) determinant encoding the S-fimbrial adhesin of uropathogenic Escherichia coli strains was found to be located on a pathogenicity island of uropathogenic E. coli strain 536. This pathogenicity island, designated PAI III(536), is located at 5.6 min of the E. coli chromosome and covers a region of at least 37 kb between the tRNA locus thrW and yagU. As far as it has been determined, PAI III(536) also contains genes which code for components of a putative enterochelin siderophore system of E. coli and Salmonella spp. as well as for colicin V immunity. Several intact or nonfunctional mobility genes of bacteriophages and insertion sequence elements such as transposases and integrases are present on PAI III(536). The presence of known PAI III(536) sequences has been investigated in several wild-type E. coli isolates. The results demonstrate that the determinants of the members of the S-family of fimbrial adhesins may be located on a common pathogenicity island which, in E. coli strain 536, replaces a 40-kb DNA region which represents an E. coli K-12-specific genomic island.